Factors to consider in selecting and antidepressant. Symposium. Dallas TX USA, 1994/01/28.
The goal of this paper is to increase the psychiatrist's awareness of issues and methods in pharmacoeconomics with the hope that this will lead to greater physician involvement in the ongoing cost-management debates.
This paper will first examine the underlying dynamics of health economics as they relate to the treatment of major depressive disorder.
It will then discuss cost-benefit factors in antidepressant pharmacotherapy with special focus on the economic implications of clinically relevant differences among antidepressant drug classes.
The paper ends with a review of methods for the economic analysis of drug therapies and a discussion of research needs in this area.
Mots-clés Pascal : Etat dépressif, Trouble humeur, Antidépresseur, Psychotrope, Chimiothérapie, Traitement, Choix, Analyse avantage coût, Economie santé, Analyse coût efficacité, Prescription médicale, Article synthèse, Homme
Mots-clés Pascal anglais : Depression, Mood disorder, Antidepressant agent, Psychotropic, Chemotherapy, Treatment, Choice, Cost benefit analysis, Health economy, Cost efficiency analysis, Medical prescription, Review, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0019825
Code Inist : 002B02B02. Création : 09/06/1995.